These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 21093979

  • 1. Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells.
    Muñoz-Gámez JA, Quiles-Pérez R, Ruiz-Extremera A, Martín-Álvarez AB, Sanjuan-Nuñez L, Carazo A, León J, Oliver FJ, Salmerón J.
    Cancer Lett; 2011 Feb 01; 301(1):47-56. PubMed ID: 21093979
    [Abstract] [Full Text] [Related]

  • 2. PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
    Muñoz-Gámez JA, Martín-Oliva D, Aguilar-Quesada R, Cañuelo A, Nuñez MI, Valenzuela MT, Ruiz de Almodóvar JM, De Murcia G, Oliver FJ.
    Biochem J; 2005 Feb 15; 386(Pt 1):119-25. PubMed ID: 15456408
    [Abstract] [Full Text] [Related]

  • 3. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
    García S, Bodaño A, Pablos JL, Gómez-Reino JJ, Conde C.
    Ann Rheum Dis; 2008 May 15; 67(5):631-7. PubMed ID: 17890271
    [Abstract] [Full Text] [Related]

  • 4. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    Pogrebniak A, Schemainda I, Pelka-Fleischer R, Nüssler V, Hasmann M.
    Eur J Med Res; 2003 Oct 22; 8(10):438-50. PubMed ID: 14594650
    [Abstract] [Full Text] [Related]

  • 5. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Luo Q, Li Y, Deng J, Zhang Z.
    Chem Biol Interact; 2015 Jan 25; 226():12-22. PubMed ID: 25499136
    [Abstract] [Full Text] [Related]

  • 6. 4-Amino-1,8-naphthalimide: a novel inhibitor of poly(ADP-ribose) polymerase and radiation sensitizer.
    Schlicker A, Peschke P, Bürkle A, Hahn EW, Kim JH.
    Int J Radiat Biol; 1999 Jan 25; 75(1):91-100. PubMed ID: 9972795
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
    Sharma SS, Kumar A, Kaundal RK.
    Life Sci; 2008 Mar 12; 82(11-12):570-6. PubMed ID: 18262571
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    Luo Q, Li Y, Lai Y, Zhang Z.
    J Toxicol Sci; 2015 Jun 12; 40(3):349-63. PubMed ID: 25972196
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
    Kuo ML, Shen SC, Yang CH, Chuang SE, Cheng AL, Huang TS.
    Oncogene; 1998 Oct 29; 17(17):2225-34. PubMed ID: 9811453
    [Abstract] [Full Text] [Related]

  • 13. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
    Yuan XW, Zhu XF, Huang XF, Sheng PY, He AS, Yang ZB, Deng R, Feng GK, Liao WM.
    Acta Pharmacol Sin; 2007 Nov 29; 28(11):1835-41. PubMed ID: 17959036
    [Abstract] [Full Text] [Related]

  • 14. Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone.
    Holl V, Coelho D, Weltin D, Hyun JW, Dufour P, Bischoff P.
    Anticancer Res; 2000 Nov 29; 20(5A):3233-41. PubMed ID: 11062748
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.
    Radons J, Heller B, Bürkle A, Hartmann B, Rodriguez ML, Kröncke KD, Burkart V, Kolb H.
    Biochem Biophys Res Commun; 1994 Mar 30; 199(3):1270-7. PubMed ID: 8147870
    [Abstract] [Full Text] [Related]

  • 16. The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks.
    Smith LM, Willmore E, Austin CA, Curtin NJ.
    Clin Cancer Res; 2005 Dec 01; 11(23):8449-57. PubMed ID: 16322308
    [Abstract] [Full Text] [Related]

  • 17. PARP-1 is involved in autophagy induced by DNA damage.
    Muñoz-Gámez JA, Rodríguez-Vargas JM, Quiles-Pérez R, Aguilar-Quesada R, Martín-Oliva D, de Murcia G, Menissier de Murcia J, Almendros A, Ruiz de Almodóvar M, Oliver FJ.
    Autophagy; 2009 Jan 01; 5(1):61-74. PubMed ID: 19001878
    [Abstract] [Full Text] [Related]

  • 18. Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase.
    Brock WA, Milas L, Bergh S, Lo R, Szabó C, Mason KA.
    Cancer Lett; 2004 Mar 18; 205(2):155-60. PubMed ID: 15036647
    [Abstract] [Full Text] [Related]

  • 19. Induction of apoptosis by the inhibitors of poly(ADP-ribose)polymerase in HeLa cells.
    Ghosh U, Bhattacharyya NP.
    Mol Cell Biochem; 2009 Jan 18; 320(1-2):15-23. PubMed ID: 18695944
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.